drugset / Trial / NCT00553449
Open Label Study Evaluating Different Dosing Regimens of Rabeprazole in Gastro-esophageal Reflux Disease (GERD) Patients With Night-time Heartburn Symptoms.
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the effect of each of the rabeprazole treatment regimens on nocturnal heartburn symptoms.
Timeline
- Start
- 2004-07
- Primary completion
- —
- Completion
- 2005-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rabeprazole | Small molecule | 10 mg | — |
| Subject | Rabeprazole | Small molecule | 20 mg | — |